Cost Comparison Shows Intrauterine Balloon Tamponade as Practical First-Line Option for Postpartum Hemorrhage: Study
Netherlands: A recent study published in the International Journal of Gynecology & Obstetrics sheds light on the cost-effectiveness of two commonly used interventions for managing persistent postpartum hemorrhage (PPH)—intrauterine balloon tamponade and uterine artery embolization. While both approaches showed similar overall costs, the study highlights that balloon tamponade, being less invasive and easier to administer, may be a more practical and accessible first-line option, particularly in settings with limited resources.
The study analyzed the cost-effectiveness of two primary interventions for managing persistent postpartum hemorrhage (PPH): intrauterine balloon tamponade and uterine artery embolization. The findings suggest that while both strategies have similar financial implications, intrauterine balloon tamponade may offer practical advantages due to its less invasive approach.
Persistent PPH, defined as postpartum bleeding unresponsive to initial treatments, remains a significant cause of maternal morbidity. In the study, Lisanne R. Bonsen, Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, the Netherlands, and colleagues conducted a cost comparison between two clinical management strategies by retrospectively analyzing a matched cohort of women who underwent either intrauterine balloon tamponade (scenario 1) or uterine artery embolization (scenario 2).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.